1256 related items for PubMed ID: 16510745
1.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
2. Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW, SENTINEL Investigators.
J Neurol Sci; 2010 May 15; 292(1-2):28-35. PubMed ID: 20236661
[Abstract] [Full Text] [Related]
3. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.
Kleinschmidt-DeMasters BK, Tyler KL.
N Engl J Med; 2005 Jul 28; 353(4):369-74. PubMed ID: 15947079
[Abstract] [Full Text] [Related]
4.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
5.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
6. Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Togha M, Karvigh SA, Nabavi M, Moghadam NB, Harirchian MH, Sahraian MA, Enzevaei A, Nourian A, Ghanaati H, Firouznia K, Jannati A, Shekiba M.
Mult Scler; 2010 Jul 28; 16(7):848-54. PubMed ID: 20488825
[Abstract] [Full Text] [Related]
7. Selective treatment of multiple sclerosis.
Ropper AH.
N Engl J Med; 2006 Mar 02; 354(9):965-7. PubMed ID: 16510751
[No Abstract] [Full Text] [Related]
8. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P, FREEDOMS Study Group.
N Engl J Med; 2010 Feb 04; 362(5):387-401. PubMed ID: 20089952
[Abstract] [Full Text] [Related]
9. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
Minagar A, Alexander JS, Schwendimann RN, Kelley RE, Gonzalez-Toledo E, Jimenez JJ, Mauro L, Jy W, Smith SJ.
Arch Neurol; 2008 Feb 04; 65(2):199-204. PubMed ID: 18071030
[Abstract] [Full Text] [Related]
10. Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis.
Zivadinov R, Dwyer MG, Hussein S, Carl E, Kennedy C, Andrews M, Hojnacki D, Heininen-Brown M, Willis L, Cherneva M, Bergsland N, Weinstock-Guttman B.
Mult Scler; 2012 Aug 04; 18(8):1125-34. PubMed ID: 22194217
[Abstract] [Full Text] [Related]
11.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
13. [Natalizumab in the treatment of multiple sclerosis].
Horga A, Horga de la Parte JF.
Rev Neurol; 2012 Aug 04; 45(5):293-303. PubMed ID: 17876741
[Abstract] [Full Text] [Related]
14.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
15. Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
Kappos L, Traboulsee A, Constantinescu C, Erälinna JP, Forrestal F, Jongen P, Pollard J, Sandberg-Wollheim M, Sindic C, Stubinski B, Uitdehaag B, Li D.
Neurology; 2006 Sep 26; 67(6):944-53. PubMed ID: 17000959
[Abstract] [Full Text] [Related]
16.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
18. Assessing disability progression with the Multiple Sclerosis Functional Composite.
Rudick RA, Polman CH, Cohen JA, Walton MK, Miller AE, Confavreux C, Lublin FD, Hutchinson M, O'Connor PW, Schwid SR, Balcer LJ, Lynn F, Panzara MA, Sandrock AW.
Mult Scler; 2009 Aug 26; 15(8):984-97. PubMed ID: 19667023
[Abstract] [Full Text] [Related]
19. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.
Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D.
N Engl J Med; 2005 Jul 28; 353(4):375-81. PubMed ID: 15947078
[Abstract] [Full Text] [Related]
20. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
Ravnborg M, Sørensen PS, Andersson M, Celius EG, Jongen PJ, Elovaara I, Bartholomé E, Constantinescu CS, Beer K, Garde E, Sperling B.
Lancet Neurol; 2010 Jul 28; 9(7):672-80. PubMed ID: 20542736
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
